Medplus Health Services Ltd (MEDPLUS) is currently trading at 779.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

MedPlus Health Services Limited is primarily engaged in pharmaceutical retail, diagnostic services, and pathology services with a strong focus on expanding its retail pharmacy network and offering MedPlus-branded pharmaceutical products. Despite facing challenges, MedPlus has maintained a growth trajectory by opening 145 new stores in Q2 FY '26 and planning 600 additional outlets over the fiscal year. This expansion strategy strongly positions the company in the retail pharmacy market. The company recorded a substantial Y-o-Y revenue growth of 6.3% on a net basis in Q2 FY '26, with its pharmacy operations now constituting 99% of its total revenue. This underlines the importance of its pharmacy business to overall financial performance. MedPlus has improved its margin profile with an operating EBITDA of INR 887 million, representing 5.3% of its consolidated revenue, reflecting effective cost management and operational efficiency improvements. Private label products have seen impressive growth, with private label pharma sales reaching 19.8% of GMV in the current quarter, marking a strategic shift towards higher-margin own-brand products.

Over the past 52 weeks, Medplus Health Services Ltd has traded between a low of ₹603.00 and a high of ₹1,052.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Medplus Health Services Ltd has a market capitalization of approximately 9,457.00. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Medplus Health Services Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 48.48 and operates in the Retail sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Medplus Health Services Ltd (MEDPLUS) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 9,457.00 Cr, Medplus Health Services Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Medplus Health Services Ltd operates in the Retail sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Medplus Health Services Ltd is 48.48. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Medplus Health Services Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.

Key risks associated with Medplus Health Services Ltd include sector-specific challenges in the Retail industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.